Skip to content

Laura Gunter: Biotech policies should protect patients, innovation

Laura Gunter: Biotech policies should protect patients, innovation The ongoing response to the COVID-19 pandemic has highlighted the critical role of the North Carolina life sciences industry in battling our most serious public health threats. When faced with the threat of COVID-19, biotechnology companies — many based right here in North Carolina — answered the…

Read More